Biotech Values

[binchey]

Thanks Peter, we know that there is a meeting between FDA and ARia. Assuming potentially positive impact of all this favorable data, i wonder how fast iclusig can return to the market in your opinion? Do you think FDA might require additional trial data with lowered dose?